Labcorp Holdings
LH
311.97
+0.26
+0.08%
Labcorp Holdings
US · LH
#790 by market cap
Listed 1970
311.97
+0.26
+0.08%
Live - 5344 symbols - heartbeat 312s ago
· 2026-10-08 07:38
Pre-market
311.97
0.00%
After-hours
311.97
0.00%
- Market cap
- 25.30B
- P/E (TTM)i
- 25.80
- P/Bi
- 2.94
- EPSi
- 10.46
- Div yieldi
- 0.92%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on LH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 12 analysts
Buy
Avg price target
347.67 +11.4%
Price target rangecurrent 311.97
Low309.00
Avg347.67
High380.00
Buy 83%
Hold 17%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-23 | Leerink Partners | -- | BUY | -- |
| 2026-09-21 | Truist Financial | -- | BUY | 365.00 |
| 2026-09-11 | William Blair | -- | BUY | -- |
| 2026-09-11 | UBS | -- | BUY | 380.00 |
| 2026-09-11 | Truist Financial | -- | BUY | 350.00 |
| 2026-09-11 | Evercore | -- | BUY | 340.00 |
| 2026-09-11 | Barclays | -- | HOLD | 330.00 |
| 2026-09-03 | Evercore | -- | BUY | 340.00 |
| 2026-08-26 | J.P. Morgan | -- | BUY | -- |
| 2026-08-10 | Mizuho Securities | -- | BUY | 355.00 |
| 2026-08-04 | Piper Sandler | -- | HOLD | 309.00 |
| 2026-08-03 | J.P. Morgan | -- | BUY | 360.00 |
| 2026-07-31 | UBS | -- | BUY | 361.00 |
| 2026-07-31 | Truist Financial | -- | BUY | 350.00 |
| 2026-07-31 | Baird | -- | BUY | 352.00 |
| 2026-07-31 | Morgan Stanley | -- | BUY | 338.00 |
| 2026-07-31 | Barclays | -- | HOLD | 320.00 |
| 2026-07-30 | William Blair | -- | BUY | -- |
| 2026-07-30 | BofA Securities | -- | BUY | 360.00 |
| 2026-07-30 | Barclays | -- | HOLD | 320.00 |
| 2026-07-13 | BofA Securities | -- | BUY | 320.00 |
| 2026-06-02 | Argus Research | -- | BUY | 310.00 |
| 2026-05-04 | Truist Financial | -- | BUY | 320.00 |
| 2026-05-01 | Truist Financial | -- | BUY | -- |
| 2026-05-01 | Baird | -- | BUY | 334.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | -- | ±5.86% | +2.73% (in line) |
| 2026/Q1 | 2026-04-30 | -- | ±5.09% | -0.13% (in line) |
| 2025/Q4 | 2026-02-17 | -- | ±3.30% | -2.11% (in line) |
| 2025/Q3 | 2025-10-28 | -- | ±4.55% | -5.79% (beat) |
| 2025/Q2 | 2025-07-24 | -- | ±6.24% | +6.86% (beat) |
| 2025/Q1 | 2025-04-29 | -- | ±6.72% | +4.71% (in line) |
| 2024/Q4 | 2025-02-06 | -- | ±5.85% | -0.90% (in line) |
| 2024/Q3 | 2024-10-24 | -- | ±7.99% | +4.62% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±6.42% | +8.33% (beat) |
| 2024/Q1 | 2024-04-25 | -- | ±5.02% | -4.61% (in line) |
| 2023/Q4 | 2024-02-15 | -- | ±5.18% | -2.62% (in line) |
| 2023/Q3 | 2023-10-26 | -- | ±8.95% | +4.16% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:38:19 · For reference only, not investment advice and not tailored to your situation.